申请人:Incyte Corporation
公开号:US20140377292A1
公开(公告)日:2014-12-25
The present invention is directed to modulators of indoleamine 2,3-dioxygenase (IDO), as well as compositions and pharmaceutical methods thereof.
本发明涉及色
氨酸2,3-双加氧酶(
IDO)的调节剂,以及其组合物和制药方法。